<DOC>
	<DOCNO>NCT00016536</DOCNO>
	<brief_summary>The purpose study find bad effect BufferGel PRO 2000/5 Gel apply penis HIV-infected men . Microbicides product use woman place vagina prevent pass HIV 1 person another sex . Studies show 2 investigational microbicides , BufferGel PRO 2000/5 Gel , safe acceptable woman HIV-negative men . It important see side effect product men woman see difference side effect circumcise uncircumcised men .</brief_summary>
	<brief_title>Effects BufferGel PRO 2000/5 Gel Men</brief_title>
	<detailed_description>Topical microbicides product design prevent sexual transmission HIV disease pathogen . Studies show nonoxynol-9 , detergent microbicide , cause mucosal erosion ulceration increase risk HIV infection . Attention give develop non-detergent topical microbicides , BufferGel PRO 2000/5 Gel . Studies show product safe acceptable vaginal use [ AS PER AMENDMENT 08/20/01 : `` however , none clinical study date investigate effect penile epithelium urethral mucosa '' replace : Phase I trial also conduct assess safety BufferGel PRO 2000/5 Gel ( P ) penile epithelium urethral mucosa . In 1 trial , HIV-uninfected men apply either PRO 2000/5 gel contain inactive ingredient PRO 2000/5 7 day . A patient report mild symptom genital itching , tingle , irritation , dryness , discoloration , flake dry gel . In similar trial compare BufferGel K-Y Jelly , patient report similar symptom . ] It important determine whether frequency severity adverse event experience men comparable observe among woman . It also important determine whether adverse event similar circumcise uncircumcised men . Patients assign randomly 1 6 possible sequence product use . Patients complete 3 week nightly product application ( 7 consecutive night BufferGel , PRO 2000/5 Gel , placebo gel ) separate one-week washout product-use period . Patients apply gel shaft glans penis bedtime , leave minimum 6 hour , wash next morning . Patients maintain diary product application removal , side effect , use medication . Follow-up evaluation , include genital exam urine testing , perform product-use washout period . [ AS PER AMENDMENT 08/20/01 : Digital photograph take observed abnormality normal area need clinical decision make and/or documentation purpose . ] In addition , adherence assess , patient diary review , product acceptability questionnaire administer product-use period . Patients receive monetary compensation participation .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Inclusion Criteria Patients may eligible study : Are male least 18 year old . Are HIVpositive . Have CD4 cell count 200 within year study entry . Can speak write English . Can provide address , phone number , contact information . Agree apply product penis 3 week product use . Agree sex , masturbate , perform activity may irritate penis 3 week product use . Exclusion Criteria Patients eligible study : Are allergic ingredient study product . Have inflammation urethra ( painful urination , burning , itch ) past . Have penis skin reaction , eczema , psoriasis , severe seborrheic dermatitis , similar problem past . Have nonHIV sexually transmitted disease ( STD ) , include genital herpes outbreak , past 6 month . Have change antiHIV drug past 30 day . Have take part study investigational product past 30 day . Have break skin penis . Have sign symptom STD . Apply topical product ( e.g. , creams ointment ) penis . Have abnormal find physical genital exam . Have positive result urine leukocyte esterase ( LE ) test . Use drug would affect study , doctor 's opinion .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Antiviral Agents</keyword>
	<keyword>Mucous Membrane</keyword>
	<keyword>Spermatocidal Agents</keyword>
	<keyword>Penis</keyword>
	<keyword>Epithelium</keyword>
	<keyword>PRO 2000</keyword>
	<keyword>Urethra</keyword>
	<keyword>HIV Seronegativity</keyword>
</DOC>